KRM Ayurveda Ltd IPO
Healthcare
Price Band
₹128 – ₹135
Lot Size
1000
Minimum Bid Quantity
2000
Minimum Investment
₹270000
Issue Size
₹77.49Cr
Opens
2026-01-21
Closes
2026-01-23
Listing
29-01-2026
Subscription Status
Qualified Institutional Buyers
61.52 x
Non-Institutional Investor
86.51 x
Retail Individual Investor
51.61 x
Total
63.75 x
IPO Details
Issue Type
EQUITY
Face Value
₹10
Tick Size
1
ISIN
INE1MTV01019
Pre-Apply Available
No
Daily Bidding Time
10:00:00 - 17:00:00
About the Company
KRM Ayurveda is a healthcare company that operates a network of Ayurveda-based hospitals and clinics providing treatment for chronic and lifestyle-related health conditions. Its services cover inpatient and outpatient care for disorders such as kidney disease, liver cirrhosis, diabetes, fatty liver, arthritis, and other long-term ailments, along with post-operative rehabilitation. The company provides Panchakarma procedures, runs focused clinics for orthopaedic issues, skin and hair concerns, women’s health, and elderly care, and offers structured wellness plans for stress, weight, and preventive health. It also dispenses its own and other approved Ayurvedic medicines through in-house pharmacies and provides diet, nutrition, and yoga guidance. Established in 2019, the company currently operates six hospitals and five clinics at different locations in India and serves overseas patients through online consultations and medicine sales, using teleconsultation channels to extend access to its doctors beyond its physical centres.
Pros
- • KRM Ayurveda claims to follow GMP-certified processes and holds an ISO 9001:2015 certification for its quality management system.
- • KRM Ayurveda claims that its promoter, Dr Puneet Dhawan, has received several recognitions in the Ayurveda and wellness sector. These include the Ayush Young Entrepreneur Award in 2024 and the “Best Ayurveda Doctor in India” title at the International Fame Awards 2023. The company also notes invitations linked to award platforms and recognition events such as TEDx Panoroad in 2024 and the 2025 conference on “Sustainable Healthcare Solutions.”
Cons
- • KRM Ayurveda has reported relatively high employee attrition in recent years, with attrition rates of 31.75 percent in FY25, 78.47 percent in FY24, and 37.04 percent in FY23, based on average employee counts of 359, 432, and 405, respectively. This level of turnover, including among frontline and technical staff, can increase recruitment and training costs, disrupt continuity of service delivery, and lead to loss of institutional knowledge. If the company is unable to attract, train, and retain skilled professionals in critical roles, its operations, customer service quality, and long-term growth plans may be adversely affected.
- • Delhi accounted for Rs 22.16 crore (28.94 percent) of the company’s revenue in FY25, Rs 30.21 crore (44.98 percent) in FY24, and Rs 51.25 crore (57.40 percent) in FY23. Any adverse political, social, or economic developments, regulatory changes, or operational disruptions in this region could negatively impact the company’s business, results of operations, and financial condition.
- • The company reported negative cash flow from operations amounting to Rs 0.03 crore in FY25 and Rs 0.89 crore in FY24. This was mainly due to higher cash being tied up in inventories and an increase in trade receivables, while FY24 outflows were mainly due to an increase in other current assets and a decrease in trade payables. Additionally, negative cash flow from investing activities amounted to Rs 4.33 crore in FY25, Rs 0.13 crore in FY24, and Rs 22.94 crore in FY23, on account of the purchase of property, plant, and equipment. If such negative cash flows continue, the company may face constraints on liquidity, impacting its financial condition and ability to support ongoing operations.
Get real-time IPO alerts on WhatsApp
Opening reminders • Subscription updates • GMP alerts • Allotment results
Start WhatsApp Alerts